Indaptus Therapeutics (INDP) Current Assets (2020 - 2026)
Indaptus Therapeutics (INDP) posted quarterly Current Assets of $2.2 million for Q1 2026, down 56.04% year-over-year from $5.0 million in Q1 2025, and down 76.58% quarter-over-quarter from $9.3 million in Q4 2025.
Indaptus Therapeutics (INDP) Current Assets (2020 - 2026) Analysis & Trends
Indaptus Therapeutics' Current Assets history runs 7 years deep, the most recent figure standing at $2.2 million for Q1 2026.
- In Q1 2026, Current Assets fell 56.04% year-over-year to $2.2 million; the TTM figure through Mar 2026 stood at $2.2 million (down 56.04% YoY), while the FY2025 annual figure was $9.3 million, up 40.67% from the prior year.
- Current Assets for Q1 2026 stood at $2.2 million, down from $9.3 million in the prior quarter.
- The five-year high for Current Assets was $36.9 million in Q1 2022, with the low at $2.2 million in Q1 2026.
- The 5-year median for Current Assets is $10.3 million (2024), against an average of $15.4 million.
- The sharpest annual moves came in 2022 and 2024: Current Assets jumped 203.64% in 2022, then slumped 62.32% in 2024.
- Indaptus Therapeutics' Current Assets stood at $27.2 million in 2022, then slumped by 48.63% to $14.0 million in 2023, then slumped by 52.71% to $6.6 million in 2024, then soared by 40.67% to $9.3 million in 2025, then tumbled by 76.58% to $2.2 million in 2026.
- Business Quant data shows INDP's Current Assets at $2.2 million in Q1 2026, $9.3 million in Q4 2025, and $6.4 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 12.54 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 18.45 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | 8.07 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 5.82 Bn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 7.22 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 4.62 Bn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 18.80 Bn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 1.63 Bn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 1.76 Bn |
| 10 | Indaptus Therapeutics | 146.91 Mn | 135.35 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 2.18 Mn |
| Dec 31, 2025 | 9.31 Mn |
| Sep 30, 2025 | 6.44 Mn |
| Jun 30, 2025 | 6.41 Mn |
| Mar 31, 2025 | 4.96 Mn |
| Dec 31, 2024 | 6.62 Mn |
| Sep 30, 2024 | 7.63 Mn |
| Jun 30, 2024 | 7.49 Mn |
| Mar 31, 2024 | 10.29 Mn |
| Dec 31, 2023 | 14.00 Mn |
| Sep 30, 2023 | 16.84 Mn |
| Jun 30, 2023 | 19.87 Mn |
| Mar 31, 2023 | 22.15 Mn |
| Dec 31, 2022 | 27.24 Mn |
| Sep 30, 2022 | 29.59 Mn |
| Jun 30, 2022 | 33.27 Mn |
| Mar 31, 2022 | 36.92 Mn |
| Dec 31, 2021 | 40.39 Mn |
| Sep 30, 2021 | 43.85 Mn |
| Jun 30, 2021 | 18.79 Mn |